EverHint Signal — SMA20 × SMA50 Crossover — December 30, 2025

What This Signal Is (Quick)

The SMA20 × SMA50 crossover strategy tracks when the 20-day simple moving average crosses the 50-day simple moving average. This is the most stable of all moving average crossover strategies—fewer signals, but highest quality with minimal whipsaw risk.

Buy signals ("Golden Cross") fire when SMA(20) crosses above SMA(50) on today's close. Short-term momentum (20 days) is exceeding the medium-term trend (50 days), signaling bullish trend confirmation with high reliability. These setups are ideal for medium-term trend following with 4-12 week holding periods.

Sell signals ("Death Cross") fire when SMA(20) crosses below SMA(50). Short-term momentum weakens below the medium-term trend, providing bearish trend confirmation. These can signal exit points for existing positions or alert to potential trend reversals.

This strategy uses simple moving averages (not exponential), which provides maximum stability and reduces noise. The signals are less frequent than EMA-based strategies but carry higher conviction. This is an experimental scanner—signals are for educational use, back-testing, and research, not direct trading recommendations.

How We Ranked Today (Reader Version)

Today's signals are ranked primarily by RSI(14), with lower RSI values ranking higher for buy signals (more oversold = better risk/reward potential) and lower RSI ranking higher for sell signals (more oversold = stronger breakdown momentum).

We overlay three additional data layers:

• Insider Net (USD): Net insider buying (purchases minus sales) over the last 90 days. Positive = net buying (bullish), negative = net selling (bearish). Awards, exercises, and tax payments excluded—only open-market P and S transactions count.

• Days → Earnings: Days until the next earnings report. Closer earnings = higher event risk and volatility.

• Analyst Coverage: Consensus estimates provide Wall Street's expectations context.

These signals are for educational use and back-testing. They're not financial advice. Do your own due diligence.

📈 Buy-Side Signals ("Golden Cross")

Today's scanner identified 16 "Golden Cross" buy signals where SMA(20) crossed above SMA(50), spanning Technology, Industrials, Financial Services, Consumer Cyclical, Communication Services, and Real Estate.

Field Notes:

• Quality Over Quantity: Only 16 buy signals reflect the SMA20×SMA50 strategy's high bar—these are confirmed medium-term trend shifts, not noise.

• RSI Distribution: Buy signals range from BAH at 36.08 (slightly oversold, ideal entry zone) to EG at 91.26 (extremely overbought but confirming strong momentum). Most cluster in the 40-75 range—healthy momentum without extreme conditions.

• Sector Diversity: Strong representation across Technology (5), Communication Services (3), Industrials (2), Consumer Cyclical (3), plus single entries in Energy, Healthcare, Real Estate, and Financial Services. No single sector dominates.

• Insider Activity: Notable insider buying at DASH (+$4.66M from director Alfred Lin purchasing 23,106 shares), BAH (+$2.01M from CEO Horacio Rozanski), KNTK (+$276.6K from officer Jamie Welch), ITGR (+$181.7K from executives), and CNXC (+$84.1K from CEO Christopher Caldwell). Strong insider conviction on these crossovers.

• Earnings Proximity: CNXC reports in just 22 days, MMYT in 23 days, FFIV in 28 days—consider tightened stops. EG, BAH, ARW, and most others have 30+ day runways.

Recent Headlines

• BAH - Booz Allen Hamilton: Received "Hold" average rating from 17 analysts (3 sell, 11 hold, 2 buy, 1 strong buy). CEO Horacio Rozanski purchased 23,800 shares at $84.66 in late October, demonstrating strong insider confidence. Recently added to Zacks Rank #5 (Strong Sell) list on Dec 24th.

• DASH - DoorDash: Director Alfred Lin made significant purchases in late November (23,306 shares totaling $4.66M at $199.83). CEO Tony Xu transferred shares to indirect ownership structures.

• FFIV - F5: Management executed large equity awards in early November, with CEO Francois Locoh-Donou receiving 19,163 shares. Director Alan Higginson sold 1,309 shares at $237.11 in early December.

• CNXC - Concentrix: CEO Christopher Caldwell purchased 2,000 shares at $42.03 in late October. Company scheduled Q4 FY2025 earnings release for January 13, 2026. Institutional activity shows mixed signals with some funds taking new positions.

• TTWO - Take-Two Interactive: No recent insider activity or major news. Strong RSI at 64.03 suggests healthy momentum heading into earnings (Feb 5).

• EG - Everest Re Group: RSI at 91.26 is extremely elevated—stock is deeply overbought. Golden Cross confirms strong uptrend but caution warranted at these levels.

• ITGR - Integer Holdings: Multiple insider purchases in November: CEO Payman Khales received award, EVP Diron Smith purchased 1,115 shares at $67.19, director Cheryl Capps purchased 1,600 shares at $66.70. Strong insider buying supporting the crossover.

• COLD - Americold Realty Trust: Announced new partnership with On the Run (OTR) for storage and distribution services in Adelaide, Australia, expanding into convenience retail sector. Seeking Alpha article highlighted cold storage REIT indexes growing alongside broader market during Christmas week.

• HSAI - Hesai Group: Chinese lidar manufacturer for autonomous vehicles—RSI at 74.00 suggests momentum building.

📉 Sell-Side Signals ("Death Cross")

Today's scanner caught 19 "Death Cross" sell signals where SMA(20) crossed below SMA(50), spanning Healthcare, Technology, Financial Services, Energy, and Consumer Defensive sectors.

Field Notes:

• Healthcare Dominance: 6 of 19 sell signals are Healthcare (IRON, VKTX, DYN, GILD, INCY, ADPT, ELAN)—sector showing broad technical weakness despite varied fundamentals.

• Technology Breakdown: 5 Technology names crossed below (CRDO, CLS, WK, APH, ADSK)—notable given sector's recent strength. CLS at $299.14 with $34.41B market cap is the largest cap tech name on the sell-side.

• RSI Distribution: Wide spread from deeply oversold (IRON at 21.83, WULF at 21.88) to overbought (ELAN at 84.74). The deeply oversold names suggest capitulation selling, while higher RSI names like ELAN show "distribution" patterns (selling into strength).

• Insider Activity: Massive insider selling at IRON (-$59.87M from 10% owner AI DMI LLC dumping 744,047 shares at $80.47 in October), APH (-$20.51M primarily from officer Luc Walter selling 152,318 shares at $134.65), ADPT (-$5.74M across multiple executives), VKTX (-$2.13M from executives including CEO), CRDO (-$1.73M from officers), GILD (-$1.26M from executives), and INCY (-$277.4K). Only positive insider activity: CLS (+$504.4K from director Laurette Koellner purchasing at $342.44) and KO (+$798.6K from director Max Levchin).

• Earnings Risk: APH reports in just 29 days, ARW in 37 days, VKTX/ITUB/CLS all within 36-37 days. Event risk is elevated for these names.

Recent Headlines

• IRON - Disc Medicine: Deeply oversold at RSI 21.83. Massive insider selling by 10% owner AI DMI LLC ($59.87M). Multiple insider transactions across Q4 suggest significant position liquidation.

• WULF - TeraWulf: Crypto miner pivoting to high-performance computing (HPC). Seeking Alpha article noted HPC shift is accelerating but near-term revenues may be at risk. Another article highlighted TeraWulf and Cipher Mining as "Winners in 2026's AI Acceleration Story" with multi-billion dollar hyperscaler deals (Google Cloud, AWS).

• CRDO - Credo Technology: Featured in multiple "better than crypto" stock lists for 2026. Zacks named CRDO "Bull of the Day" on Dec 26, highlighting its $27B market cap and leadership in high-bandwidth connectivity for datacenters and AI. Released 2025 ESG Report. CTO Chi Fung Cheng sold 55,000 shares at $150.77 in late December. Insider selling continues despite bullish analyst coverage.

• CLS - Celestica: Despite sell signal, fundamentals remain strong. Seeking Alpha article: "I've 3xed My Investment But I'm Still Buying More" citing 40% annual CCS growth through 2026, margin expansion, and HPS revenue growth. Zacks featured CLS in "3 AI-Powered EMS Stocks to Buy for 2026." Director Laurette Koellner purchased 1,473 shares at $342.44 in October. Stock closed at $299.14, down -1.35%.

• APH - Amphenol: Featured in multiple hardware tech and semiconductor lists for 2026 gadget boom. Massive insider selling by officer Luc Walter ($20.51M). Multiple institutional investors adjusted positions in Q3.

• ADSK - Autodesk: Compared favorably to Figma in Zacks analysis: "ADSK's scale, AI monetization and steadier earnings growth make it a safer design SaaS bet." CEO Andrew Anagnost gifted 26,268 shares in December. Stock at $299.54 with RSI 47.66.

• GILD - Gilead Sciences: Multiple executive sales throughout Q4, including CFO Andrew Dickinson, CEO Daniel O'Day (tax transactions), and EVP Deborah Telman. Director Jeffrey Bluestone sold 5,000 shares at $125.08. Net insider selling -$1.26M.

• VKTX - Viking Therapeutics: Wall Street bulls remain optimistic with "Moderate Buy" consensus from 16 analysts. However, executives sold shares in October including CEO Brian Lian ($1.36M), CFO Greg Zante ($216.5K), and COO Marianna Mancini ($216.5K). Director Charles Rowland sold $2.13M worth.

• KO - Coca-Cola: Director Max Levchin purchased shares in October (11,403 shares totaling $798.6K at ~$70), showing insider confidence despite Death Cross. Mega-cap defensive name with $301.56B market cap.

• ELAN - Elanco Animal Health: RSI at 84.74 is extremely overbought—suggests distribution (selling into strength). Death Cross confirms technical breakdown despite elevated momentum.

Vlad's Take (EverHint)

Market backdrop: U.S. equities showed mixed action on December 30th. The S&P 500 dipped -0.06% to 6,896.25, while the Nasdaq slid -0.20% to 23,419.08. The Dow underperformed with a -0.14% decline to 48,367.05. Small-caps lagged with the Russell 2000 down -0.77% to 2,500.59, suggesting defensive positioning as year-end approaches. The VIX closed at 14.32 (down from 14.43)—indicating low to normal volatility, not fear. Treasury yields edged down (10Y at 4.124%, -0.41%), providing modest support for rate-sensitive sectors. Crypto showed strength: Bitcoin +1.20% to $88,155, Ethereum +0.86% to $2,959. Overall: Consolidation mode heading into year-end—not bullish, not bearish, just sideways churn.

For today's SMA20×SMA50 crossovers, this backdrop matters because these are the highest-quality, lowest-noise signals we generate. When the slower, more stable SMAs cross, it's not a head-fake—it's a genuine medium-term trend shift. With VIX at 14.32, there's room for these trends to develop without elevated whipsaw risk.

Golden Cross highlights: The standout buy signal is BAH at $85.15 with RSI 36.08 and +$2.01M insider buying from the CEO. When a CEO drops $2M on shares and a Golden Cross fires simultaneously, that's conviction. EG at $341.26 with RSI 91.26 is technically overbought, but the Golden Cross confirms an already-strong uptrend—if you're long, trail stops; if you're watching, wait for a pullback. DASH at $228.13 with director Alfred Lin buying $4.66M worth is another compelling setup—institutional insider confidence + technical confirmation is a powerful combo. ITGR, KNTK, and CNXC also show insider buying supporting the crossovers.

For the tech-heavy buy signals (ARW, FFIV, EEFT, CNXC), note the sector rotation underway. While some tech names are breaking down (CRDO, CLS, APH, ADSK on the sell-side), others are crossing up—classic rotation within sector, not wholesale abandonment.

Death Cross caution: The sell-side is where things get interesting. IRON at RSI 21.83 with -$59.87M insider selling is a full-blown capitulation—10% owner dumped nearly $60M worth. That's not profit-taking; that's an exit. WULF at RSI 21.88 is similarly oversold, but the pivot to HPC/AI infrastructure could be a long-term positive—near-term pain, longer-term potential. APH with -$20.51M insider selling is a red flag—when insiders sell $20M+ and a Death Cross fires, respect the signal.

The most contrarian play on the sell-side is CLS at $299.14. Despite the Death Cross, fundamentals are screaming bullish: 40% annual growth, AI infrastructure tailwinds, expanding margins, and a director buying at $342 (stock now at $299). The technical breakdown may be a gift for value buyers. Similarly, KO with +$798.6K insider buying from director Max Levchin suggests the Death Cross may be temporary weakness in a mega-cap defensive name.

CRDO at $144.92 with -$1.73M insider selling is problematic. Analysts love it (Bull of the Day, featured in multiple 2026 buy lists), but insiders are selling. When Wall Street says "buy" and insiders say "sell," I trust insiders. The Death Cross confirms their skepticism.

Healthcare's broad weakness (6 sell signals) is notable. GILD, INCY, ADPT, VKTX, DYN, IRON, ELAN—diverse business models, all breaking down technically. This isn't random; it's sector-wide risk-off positioning. If you're long healthcare, tighten stops or hedge.

Earnings risk: Multiple names report within 30 days (BAH, FFIV, APH, CNXC, MMYT on buy-side; VKTX, ITUB, CLS, ARW on sell-side). The crossovers provide directional bias, but earnings volatility could override technicals short-term. Consider scaling positions or using options to manage event risk.

Bottom line: SMA20×SMA50 signals are the highest conviction crossovers we track. These aren't day-trade setups; they're 4-12 week trend followers. For Golden Crosses, I'd start with 25% positions now, add 25% on confirmed momentum, reserve 50% for pullbacks. For Death Crosses, if you're long, respect the signal and tighten stops—these are exit alerts, not buy opportunities (except for contrarian plays like CLS or KO with strong insider buying). And always, always layer your own due diligence on top of technical signals.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

🎯 Help the channel grow: like, share, or subscribe if you find value in what EverHint publishes.